A Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two 'Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19.

A Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two 'Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19.
SuperStock offers millions of photos, videos, and stock assets to creatives around the world. This image of A Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two 'Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. by David Talukdar is available for licensing today.
$24.99
Editorial Personal Use
$89.99
Editorial Presentation or Newsletters
$115.00
Editorial Website
$225.00
Editorial Magazines and Books - Interior
$59.99
RM Personal Print 3 Pack
Save $14.98
$20.00
per download
Looking for a license?
Click here, and we'll help you find it! Questions? Just ask!
DETAILS
Image Number: 6037-18011994Rights ManagedCredit Line:David Talukdar/SuperStockCollection:David TalukdarModel Release:NoProperty Release:NoResolution:5094×3349
Assam
barpeta|
bharat biotech|
bottle|
care|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|